NeuroSense Therapeutics (NRSN) Operating Leases (2022 - 2025)
NeuroSense Therapeutics (NRSN) posted Operating Leases of $72000.0 for Q4 2025, down 1.37% sequentially from $73000.0 in Q4 2024, and down 1.37% YoY from $73000.0 in Q4 2024.
NeuroSense Therapeutics (NRSN) Operating Leases (2022 - 2025) Analysis & Trends
NeuroSense Therapeutics has reported Operating Leases for 4 years, with the latest figure at $72000.0 in Q4 2025.
- Quarterly Operating Leases fell 1.37% year-over-year to $72000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $72000.0 (down 1.37% YoY) and the FY2025 annual result came in at $72000.0, down 1.37% from the prior year.
- Operating Leases eased to $72000.0 in Q4 2025 per NRSN's latest filing, from $73000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $190000.0 in Q2 2022 and troughed at $19000.0 in Q3 2024.
- A 4-year average of $85444.4 and a median of $73000.0 in 2023 frame the typical range for Operating Leases.
- The widest YoY moves for Operating Leases: up 0.0% in 2024, down 65.38% in 2024.
- Over 4 years, Operating Leases stood at $147000.0 in 2022, then slumped by 50.34% to $73000.0 in 2023, then changed by 0.0% to $73000.0 in 2024, then retreated by 1.37% to $72000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $72000.0, $73000.0, and $19000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NeuroSense Therapeutics | 9.68 Mn | 9.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 73,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 36,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Jun 30, 2022 | 190,000.00 |